Clinical utility of comprehensive circulating tumor DNA genotyping compared with standard of care tissue testing in patients with newly diagnosed metastatic colorectal cancer

BACKGROUND: Comprehensive biomarker testing is essential in selecting optimal treatment for patients with metastatic colorectal cancer (mCRC); however, incomplete genotyping is widespread, with most patients not receiving testing for all guideline-recommended biomarkers, in part due to reliance on b...

Descripción completa

Detalles Bibliográficos
Autores principales: Benavides, M., Alcaide-Garcia, J., Torres, E., Gil-Calle, S., Sevilla, I., Wolman, R., Durán, G., Álvarez, M., Reyna-Fortes, C., Ales, I., Pereda, T., Robles, M., Kushnir, M., Odegaard, J., Faull, I., Alba, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271474/
https://www.ncbi.nlm.nih.gov/pubmed/35525184
http://dx.doi.org/10.1016/j.esmoop.2022.100481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271474/
https://www.ncbi.nlm.nih.gov/pubmed/35525184
http://dx.doi.org/10.1016/j.esmoop.2022.100481

Ejemplares similares